Trinity Biotech ADR sell StockNews.com
Start price
30.03.25
/
50%
€0.41
Target price
30.03.26
-
Performance (%)
-
End price
31.03.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Trinity Biotech ADR | - | - | - |
| iShares Core DAX® | -0.676% | 4.053% | 2.212% |
| iShares Nasdaq 100 | 0.993% | 10.872% | 38.041% |
| iShares Nikkei 225® | 3.279% | 13.468% | 59.003% |
| iShares S&P 500 | 0.621% | 6.195% | 26.154% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten